Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Dynamic Contrast Enhanced Ultrasound for Predict and Assess Rectal Cancer Response After Neo-adjuvant Chemoradiation - RECT

NCT03068403 is registered in ClinicalTrials.gov with University Hospital, Bordeaux as lead sponsor.

NCT NCT03068403
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT03068403 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Dynamic Contrast Enhanced Ultrasound for Predict and Assess Rectal Cancer Response After Neo-adjuvant Chemoradiation - RECT
Lead sponsor
University Hospital, Bordeaux
Phase
Not applicable
Overall status
Terminated
Start date
June 18, 2018
Completion date
January 8, 2019
Enrollment
2 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

rectal cancer